TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Cash and Bank History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash and Bank | ₹1,165 Cr | ₹579 Cr | ₹839 Cr | ₹571 Cr | ₹403 Cr |
What is the latest Cash and Bank ratio of TORRENT PHARMACEUTICALS ?
| Year | Cash and Bank |
|---|---|
| Mar2026 | ₹1,165 Cr |
| Mar2025 | ₹579 Cr |
| Mar2024 | ₹839 Cr |
| Mar2023 | ₹571 Cr |
| Mar2022 | ₹403 Cr |
How is Cash and Bank of TORRENT PHARMACEUTICALS Trending?
| Years | Cash and Bank | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,165 Cr | 101.08 | |
| Mar2025 | ₹579 Cr | -30.94 | |
| Mar2024 | ₹839 Cr | 46.82 | |
| Mar2023 | ₹571 Cr | 41.66 | |
| Mar2022 | ₹403 Cr | - | |
Compare Cash and Bank of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹186,972.3 Cr | -1.3% | -2.4% | 33.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | -0.3% | -3.1% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,531.0 Cr | -1.3% | 2.2% | 57.5% | Stock Analytics | |
| CIPLA | ₹111,729.0 Cr | 0.2% | -2.5% | -9.1% | Stock Analytics | |
| MANKIND PHARMA | ₹105,120.0 Cr | 3.4% | 6.6% | -4.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,335.0 Cr | 3.3% | 6.1% | -6.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -1.3% |
-2.4% |
33.3% |
| SENSEX | -2.7% |
-5.7% |
-11.7% |
You may also like the below Video Courses